ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,652Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 247

$656K Total Retail Price of All Prescriptions

Rank: 15 out of 247

406 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 11,712 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
AMLODIPINE BESYLATE 556 521 1 6
OMEPRAZOLE 534 483 2 4
LEVOTHYROXINE SODIUM 502 456 3 3
LISINOPRIL 495 474 4 2
FUROSEMIDE 484 483 5 5
SIMVASTATIN 450 429 6 1
METOPROLOL TARTRATE 435 384 7 7
METFORMIN HCL 341 322 8 12
WARFARIN SODIUM 247 238 9 13
HYDROCODONE-ACETAMINOPHEN 246 208 S3 10 11
LOVASTATIN 241 207 11 22
ATORVASTATIN CALCIUM 229 206 12 8
ATENOLOL 221 211 13 10
METOPROLOL SUCCINATE 186 183 14 14
GABAPENTIN 186 183 14 17
ISOSORBIDE MONONITRATE ER 183 183 16 40
POTASSIUM CHLORIDE 180 180 17 36
RANITIDINE HCL 171 171 18 34
SERTRALINE HCL 170 152 19 16
HYDROCHLOROTHIAZIDE 168 148 20 9
ENALAPRIL MALEATE 154 137 21 61
LOSARTAN POTASSIUM 143 130 22 15
PREDNISONE 139 134 23 21
FLUOXETINE HCL 127 114 24 49
TERAZOSIN HCL 125 122 25 86
DIOVAN 115 115 26 38
TRAMADOL HCL 108 97 27 25
CRESTOR 100 91 28 30
ALENDRONATE SODIUM 96 93 29 32
ALLOPURINOL 92 90 30 33
PANTOPRAZOLE SODIUM 90 76 31 19
ROPINIROLE HCL 90 90 31 69
GLYBURIDE MICRONIZED 83 83 R 33 183
ZOSTAVAX 80 72 34 59
AZITHROMYCIN 76 72 35 48
OXYCODONE HCL 73 58 S2 36 27
GEMFIBROZIL 72 71 37 126
COMBIVENT 71 56 38 63
CARVEDILOL 69 69 39 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 63 39 51
MUPIROCIN 68 65 41 203
CLONIDINE HCL 66 49 42 101
KLOR-CON M20 66 62 42 44
LANTUS 65 60 44 39
ZOLPIDEM TARTRATE 64 63 45 24
GLIPIZIDE 61 59 46 43
DONEPEZIL HCL 60 60 47 35
PRAVASTATIN SODIUM 60 57 47 23
INSULIN SYRINGE 60 55 47 68
PROPRANOLOL HCL 57 44 50 147
FINASTERIDE 57 51 50 73
DIGOXIN 57 57 50 83
RISPERIDONE 56 56 53 58
DILTIAZEM 24HR CD 56 56 53 120
TAMSULOSIN HCL 56 55 53 31
LYRICA 56 45 53 118
AMOX TR-POTASSIUM CLAVULANATE 54 50 57 219
GLYBURIDE 54 51 R 57 41
TRIAMCINOLONE ACETONIDE 53 51 59 94
CYCLOBENZAPRINE HCL 52 44 R 60 54
PAROXETINE HCL 51 48 61 45
SPIRIVA 50 50 62 26
CLOPIDOGREL 50 50 62 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.